The link between influenza and serious heart conditions just grew stronger. A CDC study looking…
emcguinnSeptember 2, 2020
RareCyte® announces a new dual biomarker liquid biopsy assay for androgen receptor splice variant 7 (ARv7)…
emcguinnSeptember 1, 2020
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), achieved the on-schedule…
emcguinnAugust 31, 2020
UW Medicine is one of a network of U.S. sites testing a new treatment for COVID-19…
emcguinnAugust 31, 2020
Silverback Therapeutics (“Silverback”), a biopharmaceutical company advancing a pipeline of therapies that are systemically delivered but…
emcguinnAugust 28, 2020
A Phase 1 patient trial of the novel, oral therapy candidate, alpha-TEA, for advanced HER2 positive breast cancer is…
emcguinnAugust 28, 2020
Scientists have demonstrated a new way to precisely target cells by distinguishing them from neighboring…
emcguinnAugust 26, 2020
Last week the National Cancer Institute released some good news for patients with lung cancer: improved…
emcguinnAugust 26, 2020
Humans do not develop disease overnight. Rather, diseases develop gradually over years — sometimes decades…
emcguinnAugust 25, 2020
